We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Healthcare | 14.47% |
| 3 | Technology | 14.27% |
| 4 | Communication Services | 9.94% |
| 5 | Consumer Staples | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMT
1676
DELISTED
Chemtura Corporation
CHMT
| $284K | ﹤0.01% |
10,747
-2,903
| -21% | -$78.4K |
|
|
NRF
1677
DELISTED
NorthStar Realty Finance Corp.
NRF
| $284K | ﹤0.01% |
24,825
+13,246
| +114% | +$170K |
|
1678
Axalta
AXTA
$7.12B
| $282K | ﹤0.01% |
10,631
+1,875
| +21% | +$53.1K |
|
1679
InterDigital
IDCC
$8.41B
| $282K | ﹤0.01% |
5,066
+488
| +11% | +$27.6K |
|
1680
AAR Corp
AIR
$4.67B
| $280K | ﹤0.01% |
12,006
+1,410
| +13% | +$33.5K |
|
|
AXIA
1681
DELISTED
AXIA Energia
AXIA
| $279K | ﹤0.01% |
88,737
-656
| -0.7% | -$1.04K |
|
1682
Genesco
GCO
$371M
| $279K | ﹤0.01% |
4,334
-135
| -3% | -$8.93K |
|
1683
MBIA
MBI
$230M
| $279K | ﹤0.01% |
40,789
-2,415
| -6% | -$17.9K |
|
|
AXE
1684
DELISTED
Anixter International Inc
AXE
| $279K | ﹤0.01% |
5,236
+206
| +4% | +$11.8K |
|
|
IMPV
1685
DELISTED
Imperva, Inc.
IMPV
| $279K | ﹤0.01% |
6,489
-97
| -1% | -$4.07K |
|
|
CBB
1686
DELISTED
Cincinnati Bell Inc.
CBB
| $279K | ﹤0.01% |
12,224
+1,677
| +16% | +$33K |
|
1687
Graham Holdings Company
GHC
$4.91B
| $278K | ﹤0.01% |
568
-174
| -23% | -$84.8K |
|
|
N
1688
DELISTED
Netsuite Inc
N
| $278K | ﹤0.01% |
3,822
+161
| +4% | +$12.3K |
|
1689
Enviri
NVRI
$606M
| $277K | ﹤0.01% |
41,776
+4,894
| +13% | +$31.9K |
|
1690
Adeia
ADEA
$2.75B
| $276K | ﹤0.01% |
34,077
+3,478
| +11% | +$28.3K |
|
|
WIRE
1691
DELISTED
Encore Wire Corp
WIRE
| $276K | ﹤0.01% |
7,397
+246
| +3% | +$9.45K |
|
|
ICPT
1692
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $276K | ﹤0.01% |
1,931
-221
| -10% | -$32.2K |
|
|
WIBC
1693
DELISTED
WILSHIRE BANCORP INC
WIBC
| $276K | ﹤0.01% |
26,529
-255
| -1% | -$2.75K |
|
1694
Avient
AVNT
$3.76B
| $275K | ﹤0.01% |
7,794
+1,106
| +17% | +$39K |
|
|
CWEN.A
1695
DELISTED
Clearway Energy Class A
CWEN.A
| $275K | ﹤0.01% |
18,072
-1,340
| -7% | -$19.4K |
|
1696
Grand Canyon Education
LOPE
$4B
| $274K | ﹤0.01% |
6,859
+156
| +2% | +$6.58K |
|
1697
La-Z-Boy
LZB
$1.21B
| $273K | ﹤0.01% |
9,805
-342
| -3% | -$8.96K |
|
1698
Bank OZK
OZK
$5.36B
| $272K | ﹤0.01% |
7,228
-1,324
| -15% | -$52.2K |
|
|
SYNT
1699
DELISTED
Syntel Inc
SYNT
| $272K | ﹤0.01% |
6,013
-448
| -7% | -$20.2K |
|
1700
Plexus
PLXS
$6.36B
| $271K | ﹤0.01% |
6,267
+82
| +1% | +$3.46K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.